Metabolic analysis of renal lithiasis
DOI:
https://doi.org/10.35381/s.v.v8i1.3796Keywords:
Nephrolithiasis, kidney calculi, urologic diseases, (DeCS)Abstract
Objective: to analyze renal lithiasis from the metabolic point of view. Method: Descriptive documentary. Results and conclusion: Nephrolithiasis is a common condition that requires appropriate evaluation and treatment. The combination of lifestyle changes, medical therapy and interventional procedures may be necessary to address kidney stones effectively. Prevention and identification of individual risk factors are crucial to reduce stone recurrence and improve the quality of life of affected patients.
Downloads
References
Bishop K, Momah T, Ricks J. Nephrolithiasis. Prim Care. 2020;47(4):661-671. https://doi.org/10.1016/j.pop.2020.08.005
Vílchez A, Orts JA, Frédérique Scheirs S, Benavent G. Nefrolitiasis por Mesalazina [Mesalazine renal lithiasis.]. Arch Esp Urol. 2020;73(6):561-564.
Negri AL, Del Valle EE. Role of claudins in idiopathic hypercalciuria and renal lithiasis. Int Urol Nephrol. 2022;54(9):2197-2204. https://doi.org/10.1007/s11255-022-03119-2
Paik JM, Tesfaye H, Curhan GC, Zakoul H, Wexler DJ, Patorno E. Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes. JAMA Intern Med. 2024;184(3):265-274. https://doi.org/10.1001/jamainternmed.2023.7660
Kowalczyk NS, Prochaska ML, Worcester EM. Metabolomic profiles and pathogenesis of nephrolithiasis. Curr Opin Nephrol Hypertens. 2023;32(5):490-495. https://doi.org/10.1097/MNH.0000000000000903
Peerapen P, Thongboonkerd V. Kidney Stone Prevention. Adv Nutr. 2023;14(3):555-569. https://doi.org/10.1016/j.advnut.2023.03.002
Ubetagoyena Arrieta M, Areses Trapote R, Mendia Ubetagoyena J, Pérez Revuelta MS, Letona Luqui M. Renal lithiasis in pediatric patients: correlation of methods that depend on 24-hour collections with simpler methods that do not require timed urine. Actas Urol Esp (Engl Ed). 2021;45(2):146-153. https://doi.org/10.1016/j.acuro.2020.09.006
Ubetagoyena M, Areses R, Mendia J, Perez M. Urinary Saturations in Children with or without Renal Lithiasis. Arch Esp Urol. 2022;75(7):642-646. https://doi.org/10.56434/j.arch.esp.urol.20227507.93
Li X, Li B, Meng Y, et al. Treatment of recurrent renal transplant lithiasis: analysis of our experience and review of the relevant literature. BMC Nephrol. 2020;21(1):238. https://doi.org/10.1186/s12882-020-01896-5
Mayans L. Nephrolithiasis. Prim Care. 2019;46(2):203-212. https://doi.org/10.1016/j.pop.2019.02.001
Kim YN, Jung Y. Korean J Gastroenterol. 2019;73(5):260-268. https://doi.org/10.4166/kjg.2019.73.5.260
Balasubramanian P, Wanner C, Ferreira JP, et al. Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?. J Clin Endocrinol Metab. 2022;107(7):e3003-e3007. https://doi.org/10.1210/clinem/dgac154
Sarier M, Duman I, Yuksel Y, et al. Results of minimally invasive surgical treatment of allograft lithiasis in live-donor renal transplant recipients: a single-center experience of 3758 renal transplantations. Urolithiasis. 2019;47(3):273-278. https://doi.org/10.1007/s00240-018-1051-0
Martínez García RM, Jiménez Ortega AI, Salas-González MªD, Bermejo López LM, Rodríguez-Rodríguez E. Intervención nutricional en el control de la colelitiasis y la litiasis renal [Nutritional intervention in the control of gallstones and renal lithiasis]. Nutr Hosp. 2019;36(Spec No3):70-74. https://doi.org/10.20960/nh.02813
Kovacevic L. Diagnosis and Management of Nephrolithiasis in Children. Pediatr Clin North Am. 2022;69(6):1149-1164. https://doi.org/10.1016/j.pcl.2022.07.008
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Alex Jossue Fernández-Gallegos, Jenifer Alexandra Vásconez-Nina, John Alexander Valencia-Meléndez, Alex Ramón Valencia-Herrera
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
